Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Leveraging Allele-Specific Expression for Therapeutic Response Gene Discovery in Glioblastoma
Arko Sen et al.
CANCER RESEARCH (2022)
The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy
Xin Xie et al.
TRANSLATIONAL ONCOLOGY (2022)
Implications of immune cells in oncolytic herpes simplex virotherapy for glioma
Yoshihiro Otani et al.
BRAIN TUMOR PATHOLOGY (2022)
Gospel of malignant Glioma: Oncolytic virus therapy
Jinjian Li et al.
GENE (2022)
Oncolytic Zika virus promotes intratumoral T cell infiltration and improves immunotherapy efficacy in glioblastoma
Lishu Chen et al.
MOLECULAR THERAPY-ONCOLYTICS (2022)
Oncolytic Viral Therapy for Malignant Glioma and Their Application in Clinical Practice
Madison L. Shoaf et al.
NEUROTHERAPEUTICS (2022)
Tumor-Treating Fields in Glioblastomas: Past, Present, and Future
Xiaopeng Guo et al.
CANCERS (2022)
Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade
Sharmila Nair et al.
JCI INSIGHT (2021)
Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas
Nidal B. Omar et al.
NEUROSURGICAL FOCUS (2021)
Oncolytic virotherapy as immunotherapy
Alan Melcher et al.
SCIENCE (2021)
AXL receptor is required for Zika virus strain MR-766 infection in human glioblastoma cell lines
Samuel D. Zwernik et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
G. K. Friedman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Brain and other central nervous system tumor statistics, 2021
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
African-Lineage Zika Virus Replication Dynamics and Maternal-Fetal Interface Infection in Pregnant Rhesus Macaques
Chelsea M. Crooks et al.
JOURNAL OF VIROLOGY (2021)
The immune landscape of common CNS malignancies: implications for immunotherapy
Martina Ott et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
The blood-tumour barrier in cancer biology and therapy
Patricia S. Steeg
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
Yogesh R. Suryawanshi et al.
VIRUSES-BASEL (2021)
The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies
Joshua D. Bernstock et al.
VIRUSES-BASEL (2021)
Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin αvβ5 Axis
Zhe Zhu et al.
CELL STEM CELL (2020)
Safety, Tumor Reduction, and Clinical Impact of Zika Virus Injection in Dogs with Advanced-Stage Brain Tumors
Carolini Kaid et al.
MOLECULAR THERAPY (2020)
Zika Virus Infection Promotes Local Inflammation, Cell Adhesion Molecule Upregulation, and Leukocyte Recruitment at the Blood-Brain Barrier
Marion Cle et al.
MBIO (2020)
Chemical proteomics tracks virus entry and uncovers NCAM1 as Zika virus receptor
Mayank Srivastava et al.
NATURE COMMUNICATIONS (2020)
Zika virus-based immunotherapy enhances long-term survival of rodents with brain tumors through upregulation of memory T-cells
Andrew T. Crane et al.
PLOS ONE (2020)
Construction of Stable Reporter Flaviviruses and Their Applications
Coleman Baker et al.
VIRUSES-BASEL (2020)
HSV-1 Oncolytic Viruses from Bench to Bedside: An Overview of Current Clinical Trials
Marilin S. Koch et al.
CANCERS (2020)
Brain immunology and immunotherapy in brain tumours
John H. Sampson et al.
NATURE REVIEWS CANCER (2020)
Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors
Niklas Schaefer et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism
Johann Foloppe et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Mechanisms of immunotherapy resistance: lessons from glioblastoma
Christopher M. Jackson et al.
NATURE IMMUNOLOGY (2019)
Optimizing oncolytic virotherapy in cancer treatment
Kevin Harrington et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Zika virus NS5 protein inhibits cell growth and invasion of glioma
Hongjian Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Zika Virus Infection - After the Pandemic
Didier Musso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
Antonio Omuro et al.
NEURO-ONCOLOGY (2018)
Zika Virus Selectively Kills Aggressive Human Embryonal CNS Tumor Cells In Vitro and In Vivo
Carolini Kaid et al.
CANCER RESEARCH (2018)
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Talimogene laherparepvec: First in class oncolytic virotherapy
Robert M. Conry et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
Martina Da Ros et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Human glioblastoma arises from subventricular zone cells with low-level driver mutations
Joo Ho Lee et al.
NATURE (2018)
Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate
Qi Chen et al.
MBIO (2018)
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
Christopher J. LaRocca et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Tumor-Treating Fields: A Fourth Modality in Cancer Treatment
Elijah J. Mun et al.
CLINICAL CANCER RESEARCH (2018)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Zika virus has oncolytic activity against glioblastoma stem cells
Zhe Zhu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller et al.
LANCET ONCOLOGY (2017)
Neurodevelopmental protein Musashi-1 interacts with the Zika genome and promotes viral replication
Pavithra L. Chavali et al.
SCIENCE (2017)
T Cell Exhaustion in Glioblastoma: Intricacies of Immune Checkpoints
Reza Mirzaei et al.
TRENDS IN IMMUNOLOGY (2017)
Neurologic Complications Associated With the Zika Virus in Brazilian Adults
Ivan Rocha Ferreira da Silva et al.
JAMA NEUROLOGY (2017)
Combination Therapy with NHS-muIL12 and Avelumab (anti-PD-L1) Enhances Antitumor Efficacy in Preclinical Cancer Models
Chunxiao Xu et al.
CLINICAL CANCER RESEARCH (2017)
Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression
Alvaro G. Alvarado et al.
CELL STEM CELL (2017)
Genetic Ablation of AXL Does Not Protect Human Neural Progenitor Cells and Cerebral Organoids from Zika Virus Infection
Michael F. Wells et al.
CELL STEM CELL (2016)
Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth
Hengli Tang et al.
CELL STEM CELL (2016)
Zika Virus Disrupts Neural Progenitor Development and Leads to Microcephaly in Mice
Cui Li et al.
CELL STEM CELL (2016)
Expression Analysis Highlights AXL as a Candidate Zika Virus Entry Receptor in Neural Stem Cells
Tomasz J. Nowakowski et al.
CELL STEM CELL (2016)
Rapid Spread of Zika Virus in The Americas - Implications for Public Health Preparedness for Mass Gatherings at the 2016 Brazil Olympic Games
Eskild Petersen et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)
Structure of the thermally stable Zika virus
Victor A. Kostyuchenko et al.
NATURE (2016)
Zika virus cell tropism in the developing human brain and inhibition by azithromycin
Hanna Retallack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The 3.8 Å resolution cryo-EM structure of Zika virus
Devika Sirohi et al.
SCIENCE (2016)
Glioblastoma: Overview of Disease and Treatment
Mary Elizabeth Davis
CLINICAL JOURNAL OF ONCOLOGY NURSING (2016)
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Biology of Zika Virus Infection in Human Skin Cells
Rodolphe Hamel et al.
JOURNAL OF VIROLOGY (2015)
Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
Kurt Schoenfeld et al.
MOLECULAR THERAPY (2015)
Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer
Iason T. Papademetriou et al.
THERAPEUTIC DELIVERY (2015)
Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
Mario L. Suva et al.
CELL (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
Phase 1 Clinical Trial of Intratumoral Reovirus Infusion for the Treatment of Recurrent Malignant Gliomas in Adults
Kimberly P. Kicielinski et al.
MOLECULAR THERAPY (2014)
Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
Lin Cheng et al.
CELL (2013)
Prognostic value of Musashi-1 in gliomas
Rikke H. Dahlrot et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Flaviviruses: braking the entering
Theodore C. Pierson et al.
CURRENT OPINION IN VIROLOGY (2013)
Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol
Karsten Geletneky et al.
BMC CANCER (2012)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
AI Freeman et al.
MOLECULAR THERAPY (2006)
MTH-68/H oncolytic viral treatment in human high-grade gliomas
LK Csatary et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Poliovirus receptor CD155-targeted oncolysis of glioma
MK Merrill et al.
NEURO-ONCOLOGY (2004)
Intergeneric poliovirus recombinants for the treatment of malignant glioma
M Gromeier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
